Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BIOTON S.A. (DE:7U5)
FRANKFURT:7U5
Holding DE:7U5?
Track your performance easily
7U5 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.70 - €0.86
Previous Close€0.7
Volume0.00
Average Volume (3M)12.00
Market Cap
€62.15M
Enterprise Value€77.62M
Total Cash (Recent Filing)zł9.34M
Total Debt (Recent Filing)zł76.39M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Mar 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume12
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.41
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.23% Mutual Funds
― Other Institutional Investors
99.77% Public Companies and
Individual Investors
7U5 FAQ
What was BIOTON S.A.’s price range in the past 12 months?
BIOTON S.A. lowest stock price was €0.70 and its highest was €0.85 in the past 12 months.
What is BIOTON S.A.’s market cap?
Currently, no data Available
When is BIOTON S.A.’s upcoming earnings report date?
BIOTON S.A.’s upcoming earnings report date is Mar 28, 2025 which is in 125 days.
How were BIOTON S.A.’s earnings last quarter?
BIOTON S.A. released its earnings results on Nov 08, 2024. The company reported -€0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.009.
Is BIOTON S.A. overvalued?
According to Wall Street analysts BIOTON S.A.’s price is currently Overvalued.
Does BIOTON S.A. pay dividends?
BIOTON S.A. does not currently pay dividends.
What is BIOTON S.A.’s EPS estimate?
BIOTON S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BIOTON S.A. have?
BIOTON S.A. has 85,864,200 shares outstanding.
What happened to BIOTON S.A.’s price movement after its last earnings report?
BIOTON S.A. reported an EPS of -€0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.333%.
Which hedge fund is a major shareholder of BIOTON S.A.?
Currently, no hedge funds are holding shares in DE:7U5
---
BIOTON S.A. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.61%
12-Months-Change
Fundamentals
Return on Equity
-1.02%
Trailing 12-Months
Asset Growth
3.64%
Trailing 12-Months
Company Description
BIOTON S.A.
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.
---
Technical Analysis
---